ROYAL BANK OF CANADA - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 94 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$15,00019,025
+11865.4%
0.00%
Q2 2023$0159
+448.3%
0.00%
Q1 2023$0290.0%0.00%
Q4 2022$029
-66.7%
0.00%
Q3 2022$0870.0%0.00%
Q2 2022$0870.0%0.00%
Q1 2022$087
+3.6%
0.00%
Q4 2021$0
-100.0%
84
-97.2%
0.00%
Q1 2021$16,0000.0%3,0000.0%0.00%
Q4 2020$16,000
+60.0%
3,000
+200.0%
0.00%
Q2 2020$10,000
+66.7%
1,000
-48.6%
0.00%
Q1 2020$6,000
+100.0%
1,946
-36.3%
0.00%
Q4 2019$3,0000.0%3,054
+52.7%
0.00%
Q3 2019$3,000
-62.5%
2,0000.0%0.00%
Q2 2019$8,000
-20.0%
2,000
-8.9%
0.00%
Q1 2019$10,000
-16.7%
2,196
+9.8%
0.00%
Q4 2018$12,000
-14.3%
2,000
+100.0%
0.00%
Q3 2018$14,000
+16.7%
1,0000.0%0.00%
Q2 2018$12,000
+9.1%
1,000
-1.6%
0.00%
Q1 2018$11,0001,016
+1463.1%
0.00%
Q4 2017$0650.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2018
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 6,287,101$4,903,9392.63%
Syncona Portfolio Ltd 1,377,294$1,074,2891.60%
MPM BioImpact LLC 5,095,912$3,974,8111.06%
NEA Management Company, LLC 17,079,778$13,322,2271.03%
TANG CAPITAL MANAGEMENT LLC 5,166,954$4,030,2240.57%
PFM Health Sciences, LP 10,423,135$8,130,0450.38%
Matrix Capital Management Company, LP 38,974,185$30,399,8640.36%
Long Focus Capital Management, LLC 10,963,158$8,551,2630.31%
Acuitas Investments, LLC 479,764$374,2160.22%
Endurant Capital Management LP 311,944$243,3160.22%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders